Optibiotix Health Share Discussion Threads

[parob] 10/2/2019 09:24

Seed Health are working late nights and weekends to upgrade their product and prepare a UK, Canada and Australia launch next. Source: senior Seed Health employee.

[shrewdmole] 10/2/2019 09:20

Parob

Aren’t seed starting worldwide shipping soon too?

Shrewdie

[someuwin] 10/2/2019 08:53

...Yes.

One of the more annoying things about this company is that SOH takes the maximum amount of time between end of period and announcing the results (6 months for full year and 3 months for half year).

Consequently we're probably going to have to wait until end May to get the numbers from November last year.

Its difficult for investors to take positions looking to the future when we're waiting so long to get the historical numbers out of the way.

* Full Year end 30th Nov 2017 - Results announced 23rd May 2018

* Half Year end 31st May 2018 - Results announced 30 August 2018

[bazworth] 10/2/2019 08:35

When were the most recent figures released, was that the RNS on the 30th August 2018?

Many thanks

Baz

[nobbygnome] 10/2/2019 08:01

>> shrewd

So you hold £700k of stock? That really is putting money where your mouth is....

[shrewdmole] 10/2/2019 07:59

Lol

He’s made it clear we were monthly breakeven by year end 2018.

He’s also suggested revenue has grown circa 500% h2 and continues to grow.

Are results delayed not as far as I’m aware.

He also gives us as much info as he can without contravening any nda or jeopardising ongoing discussions.

I hold a good chunk here circa 1% and I certainly do not feel like soh keeps us in the dark at all. I feel he tells us as much as he can.

I for one hope he continues as he has been performing which is against any comparable outstanding to have so many deals done and so much more coming enough in several sectors.

S

[nobbygnome] 10/2/2019 07:57

Patience is a virtue. Lots of deals have been signed and a number of them are producing revenue already. Yes we don't know exactly how much but we will soon enough. I think the relevant analogy is a snowball rolling down a hill for the growing revenue....

Therein lies the opportunity for investors who CAN see the wood for the trees....

[plasybryn] 10/2/2019 07:48

You're probably correct. But how do you know? The Co. has refused time & time again to play by any normal recognised procedures with regard to numbers. Even though there are now income streams and growth is supposedly established, investors are shown no respect in this regard. They have been given no guidance or any trading data on which to calculate value as far as I know. SOH appears to consider it unnecessary to indulge shareholders preferring to treat them like mushrooms growing in the dark. How long can this go on? Why is he so opposed to come clean? Do others feel the same? Just my opinion of course.

[nobbygnome] 10/2/2019 07:35

As I have said before anyone who can look further than beyond the end of their nose, can see OPTI is a no brainer at this level. The revenue is coming and growing rapidly....and the costs are hardly changing. That is a recipe for rapid share price growth.

I will repeat again this is the most elegant company I have ever seen and the best investment opportunity I have ever seen in my 30 years of investing. Nuff said....

Nobby

[shrewdmole] 09/2/2019 23:14

Who cares as long as they are selling!!

[imnotlong] 09/2/2019 22:02

Next news India, China or Liechtenstein?

[riskybusiness1] 09/2/2019 19:59

By the looks of things Zeon is the whole package and formulate into various applications therefore no need for formulator. They will be talking to their customers now to distribute and they are big names looking on their website. Slimbiome will now be pushed by Zeon due to their interest in the 50/50 profit share. This provides not only a cost free revenue source for the manufacture of Optis own product in a major market; it provides a sales team with expertise in that culture & vast network of contacts from which to introduce Opti to. This leads to further higher valued distribution agreements in a rapidly growing market where Opti leverages its IP & trademarks on everything that is productised. Sacco are doing a tremendous job at this, so much so we have seen companies rushing to market with LPLDL before putting a separate agreement in place requiring Opti to reign them in.You have to give the bod credit for what they are actually building on such a low cash burn.

[primal123] 09/2/2019 17:34

We are now at a bargain price again, SOH has delivered everything he said he would and he will deliver again! Let's see what happens!

[incanus] 09/2/2019 15:03

Ricky, Eu only for now. I was speculating on new territory via Zeon.

[parob] 09/2/2019 14:07

Formulator first followed by multiple distributors including Tata I reckon.

[imnotlong] 09/2/2019 13:49

Hopefully you are right Risky about Tata. It’s been a long wait, especially as it was indicated a number of Indian firms would be signed up at the start of 2019.

Tata’s Q3 results which were out last week said

“Plans for Nutritional Solutions are on schedule”

Would not be surprised if SoH had some kind of news to release this week which would coincide nicely with Probiota. But would feel even more Bullish if we got a nod from Diamond to let us know something is coming.....

[incanus] 09/2/2019 12:16

From Parob's post. 'Zeon has diversified its portfolio in Medical Nutrition and has been extensively working on delivering precision nutrition for patient care.'

I wonder if this has anything to do with slimbiome medical?

[shrewdmole] 09/2/2019 11:43

Parob

Great write up.

Just need tata announced now.

S

[parob] 09/2/2019 11:29

OPTI/Zeon partnership now in the news section of Zeon's website:Zeon Joins hands with Optibiotix for Novel Weight Management TechnologyhTTp://zeonlifesciences.com/index.php/Manage_front/zeon_news/9 Zeon Lifesciences Ltd., a research driven, leading manufacturing partner for Nutraceutical and Herbal products for Indian and global markets has announced its partnership with OptiBiotix Health Plc., a life sciences company operating in one of the most progressive areas of biotechnological research.Zeon has a DSIR approved R&D lab with a team of professionals who have been actively involved in research on novel molecules and formulations to cater to the latest market demands. Zeon has diversified its portfolio in Medical Nutrition and has been extensively working on delivering precision nutrition for patient care. In the year 2018, Zeon was recognised by ASSOCHAM as "Best Nutraceutical Research Company".Zeon has a pipeline of breakthrough products which will focus on key areas of medical nutrition like cancer care, critical care, neurological supplements, etc. These will all be clinically backed up formulations which will capture the market by its efficacy.OptiBiotix identifies and develops microbial strains, compounds and formulations for use in food ingredients, supplements and active compounds that can impact on human physiology, deriving potential health benefits.Their R&D approach uses pharma grade platforms targeted on the food and dietary supplement markets protected by 65 patents / 17 families, 8 strain deposits, 28+ trademarks. With an established pipeline of microbiome modulators, the OptiBiotix team works today in the prevention and management of chronic lifestyle diseases including obesity, hypercholesterolemia and lipid profiles, and diabetes.Both the leaders have joined hands to launch Optibiotix's Slimbiome® weight management technology in India. Zeon's expertise to manufacture with purity and precision along with Optibiotix's patented technology is opening new paths for the Indian obesity market. According to National family health survey India-3 (NFHS-3), thirteen percent of women (15-49 Years) and nine percent of men (15-49 Years) were overweight or obese in 2005-06. This number has increased over the past decade. Taking it as a leading concern, Zeon will now offer a solution to the 29.8million obese people of India. With the leadership of visionary Mr Suresh Garg, Zeon has again proved its strong ability to undertake and deliver novel research.

[parob] 08/2/2019 14:06

How does it work?Step 1Share the word of the OptiBiotix Online store with a friend, family, colleague, why not even your neighbour! The important part is that the individual can't have purchased from OptiBiotix Online before.Step 2Share the discount code REFER25 with them, this means they will get a neat 25% discount off their first purchase when ordering a product (please note this code is only usable once per person).Step 3Advise them of the email address you (as an existing customer) use for the OptiBiotix Online store, and ask them to add this to the notes section of the cart page when placing an order.Step 4Upon successfully receiving an order from a referral, that includes your OptiBiotix Online email address, you will be emailed a £5 OptiBiotix Online gift voucher. Please allow 5 days for this to appear in your inbox.Step 5Repeat steps 1 to 4 for additional gift vouchers!

[dire cons] 08/2/2019 13:40

And a large ego by the sounds of it.
=~)